⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZVRA News
Zevra Therapeutics, Inc. Common Stock
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
globenewswire.com
ZVRA
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
businesswire.com
WGS
ZVRA
Form 8-K
sec.gov
ZVRA
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
ZVRA
Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer
globenewswire.com
ZVRA
Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call
globenewswire.com
ZVRA
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
globenewswire.com
ZVRA
Transpire Bio Strengthens its Leadership Team with Appointment of LaDuane Clifton as Chief Financial Officer
globenewswire.com
ZVRA
Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
businesswire.com
ZVRA
Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
businesswire.com
ZVRA